HUM-MOLGEN events: IBC's Nuclear Receptors as Drug Targets

HUM-MOLGEN -> Events -> Meetings and Conferences

January 28, 2003

IBC Life Sciences, Westin Philadelphia Hotel, Philadelphia, PA
May 19-21, 2003

IBC’s Nuclear Receptors as Drug Targets offers a comprehensive view of the latest research in this important area of drug discovery science. The meeting opens with a keynote address by Dr. Len Freedman, well-known for his work with the Memorial Sloan-Kettering Cancer Center and now with Merck. You’ll then hear new research results in the understanding of coactivators and corepressors, and be briefed on developments in methods used for the identification of orphan receptor ligands. The practical application of this research will be explored in separate therapeutic area sessions on cancer, inflammation, cardiovascular disease and diabetes.

Organized by:

IBC Life Sciences

Invited Speakers:

Keynote Address:
"Potential Mechanisms Underlying Selective Nuclear Receptor Modulators"
- Leonard Freedman, Ph.D., Senior Director, Merck

Deadline for Abstracts:

Registration:

Online: www.LifeSciencesInfo.com/2862 Phone: (508) 616-5550 x1004 Fax: (508) 616-5522 E-mail: reg@ibcusa.com

E-mail:

reg@ibcusa.com

Posted by:

James G. Prudhomme

Host: